CLINICAL CASE: SYMPTOMATICS AND EFFICIENCY OF TREATMENT OF CORONAVIRAL INFECTION ON THE BACKGROUND OF CHRONIC KIDNEY DISEASE
This article presents a clinical case of the features of the course and treatment of a new coronavirus infection against the background of the chronic renal failure of mixed origin, which developed as a result of several degenerative diseases, that are most common in the modern world. The analysis of the demonstrated medical history testifies to the negative impact of chronic kidney disease on the course of Covid infection. In addition, a significant effect on the prognosis in the treatment of an acute viral process of the stage of chronic renal failure is quite clearly traced. It is this factor, which determines the degree of an adequate response to the applied complex treatment of a new coronavirus infection, including the use of etiotropic, pathogenetic, symptomatic drugs. Modern treatment regimens for severe forms of a new coronavirus infection can improve the prognosis for this disease in people with chronic diseases of internal organs.
Gulzhakhan K. Kapanova1, https://orcid.org/0000-0001-6574-658
Alida Sh. Kaskabayeva1, https://orcid.org/0000-0002-5184-214X
Rabiga I. Alibekova1, Ainur S. Botabayeva1, Daulet K.Muzdubayev2
1 Department of Faculty Therapy, 2 intern 650 groupe,
NCJSC «Semey Medical University», Semey city, Republic of Kazakhstan.
1. Association IPH: Blood Pressure Limits Chart. In, 2008 http://www.pediatrichypertension.org/BPLimitsChart.pdf
2. Chen T., Lv Y., Lin F., Zhu J. Acute kidney injury in adult idiopathic nephrotic syndrome // Ren Fail. 2011. 33:144.
3. Cheng Y., Luo R., Wang K., Zhang M., Wang Z., Dong L. et al. Kidney disease is associated with in-hospital death of patients with COVID-19 // Kidney Int. 2020; 97(5):829–838. https://doi.org/10.1016/j.kint.2020.03.005
4. Clinicheskii Protokol diagnostiki i lecheniya koronavirusnoi infektsii Covid-19. 10 redaktsiya: Protokol - 102 ot 29.06.2020 https://diseases.medelement.com/disease 30.06.2020 [Clinical protocol Diagnostic and treatment coronavirus infection Covid19]
5. Fujimoto S., Yamamoto Y., Hisanaga S. et al. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse // Am J Kidney Dis 1991; 17:687.
6. Gbadegesin R., Lavin P., Foreman J., Winn M. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update // Pediatr Nephrol. 2011. 26:1001.
7. Guan W.J., Liang W.H., Zhao Y., Liang H.R., Chen Z.S., Li Y.M. et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis // Eur Respir J. 2020;55(5):2000547. https://doi.org/10.1183/13993003.00547-2020
8. Hu L., Chen S., Fu Y., Gao Z., Long H., Wang J.M., et al. Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China // Clin Infect Dis. 2020 May 3;ciaa539. https://doi.org/10.1101/2020.03.25.20037721
9. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification // Am J Kidney Dis, 2002, T.2 Suppl.1. P.1 - 246
10. Levey A.S., Eckardt K.U., Tsukamoto Y. et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) // Kidney Int. 2005, 67:2089.
11. Li Z., Wu M., Guo J., Yao J., Liao X., Song S. et al. Caution on Kidney Dysfunctions of 2019-nCoV Patients. 2020. https://doi.org/10.1101/2020.02.08.20021212
12. Mattoo T.K. Epidemiology, risk factors, and etiology of hypertension in children and adolescents. In UpToDate Online 16.1. UpToDate1, Inc. Niaudet P (eds.). 2008.
13. Oyelade T., Alqahtani J., Canciani G. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases:An Early Systemat - ic Review and Meta-Analysis // Trop Med Infect Dis. 2020 May 15. 5(2):80. https://doi.org/10.3390/tropicalmed5020080
14. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? // Lancet. 2020 11;395(10231):1225–1228. https://doi.org/10.1016/ S0140-6736(20)30627-9
15. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W. et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area // JAMA. 2020 Apr 22. 323(20):2052–2059. https://doi.org/10.1001/ja- ma.2020.6775
16. Schönenberger E., Ehrich J.H., Haller H., Schiffer M. The podocyte as a direct target of immunosuppressive agents // Nephrol Dial Transplant 2011; 26:18.
17. Shahid Z., Kalayanamitra R., McClafferty B., Kepko D., Ramgobin D., Patel R., et al. COVID-19 and Older Adults: What We Know // J Am GeriatrSoc. 2020;68(5):926–929. https://doi.org/10.1111/jgs.16472
18. Su H., Yang M., Wan C., Yi L.X., Tang F., Zhu H.Y, et al. Renalhisto-pathological analysis of 26 postmortem findings of patients with COVID-19 in China // Kidney Int. 2020. 98(1):219–227. https://doi.org/10.1016/j.kint.2020.04.003
19. Wuhl E., Schaefer F. Therapeutic strategies to slow chronic kidney disease progression // Pediatr Nephrol. 2008, 23: 705-716
20. Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study // Lancet Respir Med. 2020. 8(5):475–481.
Number of Views: 165
Category of articles:
Clinical case
Bibliography link
Kapanova G.K., Kaskabayeva A.Sh., Alibekova R.I., Botabayeva A.S., Muzdubayev D.K. Clinical case: symptomatics and efficiency of treatment of coronaviral infection on the background of chronic kidney disease // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 1, pp. 69-73. doi 10.34689/SH.2021.23.1.009Related publications:
RABIES - AN INFECTIOUS DISEASE WITH A FATAL OUTCOME (CLINICAL CASE)
ACTIVATION OF OPPOSITE PROCESSES – OSTEOPOROSIS AND OSTEOGENESIS IN ANKYLOSING SPONDYLITIS USING THE CLINICAL CASES
GRANULOMATOUS POLYANGITIS (WEGENER’S GRANULOMATOSIS) IN THE PRACTICE OF A RHEUMATOGIST
VARIANT OF ADULT-ONSET STILL’SDISCASE: CASE REPORT
A CASE OF DÜHRING'S DERMATITIS HERPETIFORMIS ASSOCIATED WITH SARS - COV - 2